Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May 21;100(20):e25972.
doi: 10.1097/MD.0000000000025972.

ALK-negative lung inflammatory myofibroblastic tumor in a young adult: A case report and literature review of molecular alterations

Affiliations
Review

ALK-negative lung inflammatory myofibroblastic tumor in a young adult: A case report and literature review of molecular alterations

Silvia Angela Debonis et al. Medicine (Baltimore). .

Abstract

Rationale: Inflammatory myofibroblastic tumor (IMT) is a rare mesenchymal tumor that is prevalent among children and adolescents. Surgery is the most important therapeutic approach for IMT and complete resection is recommended. Although 50% of IMTs show anaplastic lymphoma kinase (ALK) rearrangements, crizotinib has proven an effective therapeutic approach. However, the genetic landscape of this tumor is still not fully understood and treatment options are limited, especially in the majority of ALK-negative tumors.

Patient concerns: We describe the clinical case of a healthy 18-year-old female in whom a pulmonary nodule was incidentally detected.

Diagnoses: Following a small increase in the size of the nodule, the patient underwent both 18FDG-PET/CT and 68Ga-PET/CT, resulting in a suspicion of bronchial hamartoma.

Interventions: The patient underwent surgery and a salivary gland-like lung tumor was diagnosed.

Outcomes: After surgery, the patient was referred to our cancer center, where a review of the histology slides gave a final diagnosis of ALK-negative lung IMT. Given the histology, it was decided not to administer adjuvant therapy and the patient was placed in a 3-monthly follow-up program. The patient is still disease-free 2 years post-surgery.

Lessons: Although there is no standard of care for the treatment of IMT, identifying genomic alterations could help to redefine the management of patients with negative-ALK disease. Our review of the literature on IMT and other kinase fusions revealed, in addition to ALK rearrangements, the potential association of ROS1, NTRK, RET, or PDGFR beta alterations with the tumor.

PubMed Disclaimer

Conflict of interest statement

The authors have no funding and conflicts of interests to disclose.

Figures

Figure 1
Figure 1
(A) The broncopulmonary nodule detected (diameter 16 mm) was located at the apical segment of of the right lower lobe (RLL). The nodule showed (B) a SUVmax of 3.5 at 18FDG-PET/CT and (C) a SUVmax of 3.4 at 68Ga-PET/CT. SUV = standardized uptake value.
Figure 2
Figure 2
Figures with 10 × magnification show cubic cells (hematoxylin and eosin staining H&E) without atypia positive for TTF1 (A) (red arrow), CK7, and napsin and negative for CD117, chromogranin and synaptophysin. IgG plasma cells are numerous, mainly in peripheral areas, but the IgG4 ratio is normal. The spindle cell component is (B) positive for smooth actin and (C) negative for ALK.

References

    1. Gleason BC, Hornick JL. Inflammatory myofibroblastic tumors: where are we now? J Clin Pathol 2008;61:428–37. - PubMed
    1. Fletcher C, Bridge JA, Hogendoorn PC, et al. . WHO Classification of Tumours of Soft Tissue and Bone. 2013;Lyon: IARC Publications, 95–104.
    1. Coffin CM, Hornick JL, Fletcher CDM. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol 2007;31:509–20. - PubMed
    1. Cerfolio RJ, Allen MS, Nascimento AG, et al. . Inflammatory pseudotumors of the lung. Ann Thorac Surg 1999;67:933–6. - PubMed
    1. Morris SW, Naeve C, Mathew P, et al. . ALK, the chromosome 2 gene locus altered by the t (2;5) in non-Hodgkin lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK). Oncogene 1997;14:2175–88. - PubMed

MeSH terms